Oragenics Inc (AMEX:OGEN) has a beta value of 1.07 and has seen 1.49 million shares traded in the last trading session. The company, currently valued at $4.21M, closed the last trade at $0.20 per share which meant it gained $0.02 on the day or 8.89% during that session. The OGEN stock price is -1615.0% off its 52-week high price of $3.43 and 20.0% above the 52-week low of $0.16.

Oragenics Inc (AMEX:OGEN) trade information

Sporting 8.89% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OGEN stock price touched $0.20 or saw a rise of 2.44%. Year-to-date, Oragenics Inc shares have moved -46.93%, while the 5-day performance has seen it change 9.31%. Over the past 30 days, the shares of Oragenics Inc (AMEX:OGEN) have changed 2.62%.

Oragenics Inc (OGEN) estimates and forecasts

The company’s shares have lost -38.73% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 40.88% over the past 5 years. Earnings growth for 2025 is a modest 51.32% while over the next 5 years, the company’s earnings are expected to increase by 32.86%.

OGEN Dividends

Oragenics Inc is expected to release its next earnings report in June this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Also the top two Mutual Funds that are holding company’s shares are Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.31% shares in the company for having 66.29 shares of worth $12992.0 while later fund manager owns 15.75 shares of worth $3086.0 as of Mar 31, 2025 , which makes it owner of about 0.07% of company’s outstanding stock.